EMBO Young Investigator
Institut Curie, Paris | France
The dynamic nature of chromatin and transcriptional features are expected to participate in tumor evolution. Our group focuses on the study of the dynamics of histone modifications in cancer cells upon cancer treatment as well as during the initial steps of tumorigenesis.
Keywords: Histone modifications / epigenome / cancer evolution / single-cell / resistance